Literature DB >> 21459916

Chronic idiopathic urticaria and anxiety symptoms.

Filipe Barbosa1, João Freitas, António Barbosa.   

Abstract

Chronic idiopathic urticaria (CIU) is a frequently disabling disease with a negative influence on the quality of life, and can cause psychopathological symptoms, such as anxiety. Our aim is to study further anxiety symptoms on CIU patients. Both CIU patients and the control group were studied by means of validated scales for psychopathology symptoms, psychological variables and quality of life. In this study, we reported high levels of anxiety symptoms. We found statistically significant correlations between anxiety symptoms, some personality dimensions, insecure attachment styles, alexithymia and with some quality of life dimensions. CIU patients exhibit high levels of psychological distress that could potentiate difficulties at several domains, namely social, emotional, general health perception and interpersonal relationships.

Entities:  

Mesh:

Year:  2011        PMID: 21459916     DOI: 10.1177/1359105311398682

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  14 in total

1.  Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria.

Authors:  Laura Diluvio; Arianna Piccolo; Francesco Marasco; Laura Vollono; Caterina Lanna; Barbara Chiaramonte; Cinzia Niolu; Elena Campione; Luca Bianchi
Journal:  Future Sci OA       Date:  2020-08-10

2.  Sense of coherence as a protective factor in chronic urticaria.

Authors:  Alicja Ograczyk; Joanna Miniszewska; Anna Pietrzak; Anna Zalewska-Janowska
Journal:  Postepy Dermatol Alergol       Date:  2017-04-13       Impact factor: 1.837

3.  Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H1-Antihistamines in Asia, Middle-East and Africa: Results from the AWARE-AMAC study.

Authors:  Chia-Yu Chu; Anwar Al Hammadi; Nancy Agmon-Levin; Nilgun Atakan; Assem Farag; Rand K Arnaout; Suretha Kannenberg; Kanokvalai Kulthanan; Asmara Mubarak; Fares Zaitoun; Susanne Crowe; Sigrid Malfait; Kathryn Cooke; Elise L Dekker
Journal:  World Allergy Organ J       Date:  2020-04-30       Impact factor: 4.084

4.  Risk of comorbidities in patients diagnosed with chronic urticaria: A nationwide registry-study.

Authors:  Misbah Noshela Ghazanfar; Line Kibsgaard; Simon Francis Thomsen; Christian Vestergaard
Journal:  World Allergy Organ J       Date:  2020-01-25       Impact factor: 4.084

5.  A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium.

Authors:  H Lapeere; M Baeck; A Stockman; V Sabato; M Grosber; M Moutschen; J Lambert; L Vandebuerie; L de Montjoye; H Rabijns; K Allewaert; R Schrijvers
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-08-19       Impact factor: 6.166

6.  Anxiety, depression, and stress in Korean patients with chronic urticaria.

Authors:  Gil-Soon Choi; Young-Hee Nam; Chan-Sun Park; Mi-Yeong Kim; Eun-Jung Jo; Hye-Kyung Park; Hee-Kyoo Kim
Journal:  Korean J Intern Med       Date:  2020-05-27       Impact factor: 2.884

Review 7.  The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management.

Authors:  Mario Sánchez-Borges; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan Bernstein; Giorgio Walter Canonica; Motohiro Ebisawa; Maximiliano Gomez; Sandra Nora Gonzalez-Diaz; Bryan Martin; Mário Morais-Almeida; Jose Antonio Ortega Martell
Journal:  World Allergy Organ J       Date:  2021-06-01       Impact factor: 4.084

8.  ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria.

Authors:  Karsten Weller; Marcus Maurer; Clive Grattan; Alla Nakonechna; Mohamed Abuzakouk; Frédéric Bérard; Gordon Sussman; Ana M Giménez-Arnau; Javier Ortiz de Frutos; André Knulst; G Walter Canonica; Kelly Hollis; Doreen McBride; Maria-Magdalena Balp
Journal:  Clin Transl Allergy       Date:  2015-08-17       Impact factor: 5.871

9.  Sense of alexithymia in patients with anxiety disorders comorbid with recurrent urticaria.

Authors:  Ewa A Ogłodek; Anna M Szota; Marek J Just; Aleksander Araszkiewicz; Adam R Szromek
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-21       Impact factor: 2.570

10.  Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data.

Authors:  P Staubach; M Metz; N Chapman-Rothe; C Sieder; M Bräutigam; M Maurer; K Weller
Journal:  Allergy       Date:  2017-12-11       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.